WallStreetZenWallStreetZen

NASDAQ: TOI
Oncology Institute Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TOI

Based on 2 analysts offering 12 month price targets for Oncology Institute Inc

Min Forecast
$5.00+79.86%
Avg Forecast
$6.00+115.83%
Max Forecast
$7.00+151.8%

Should I buy or sell TOI stock?

Based on 2 analysts offering ratings for Oncology Institute Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TOI's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TOI as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TOI stock forecasts and price targets.

TOI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-09
lockedlocked$00.00+00.00%2026-03-09

1 of 1

Forecast return on equity

Is TOI forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is TOI forecast to generate an efficient return on assets?

Company
-4.86%
Industry
10.03%
TOI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TOI earnings per share forecast

What is TOI's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$0.30
Avg 2 year Forecast
-$0.08

TOI revenue forecast

What is TOI's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$642.5M+39.37%
Avg 2 year Forecast
$809.2M+75.52%
TOI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TOI revenue growth forecast

How is TOI forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
39.37%
Industry
8.2%
Market
26.95%
TOI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TOI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TOI vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
TOI$2.78$6.00+115.83%Strong Buy
AGL$0.60$0.92+53.34%Hold
CCRN$9.82$11.33+15.41%Buy
AUNA$4.83$7.50+55.28%Buy
AIRS$2.09N/AN/A
View Top Medical Care Facility Stocks

Oncology Institute Stock Forecast FAQ

Is Oncology Institute Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TOI) stock is to Strong Buy TOI stock.

Out of 2 analysts, 1 (50%) are recommending TOI as a Strong Buy, 1 (50%) are recommending TOI as a Buy, 0 (0%) are recommending TOI as a Hold, 0 (0%) are recommending TOI as a Sell, and 0 (0%) are recommending TOI as a Strong Sell.

If you're new to stock investing, here's how to buy Oncology Institute stock.

What is TOI's earnings growth forecast for 2026-2027?

(NASDAQ: TOI) Oncology Institute's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 17.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,671.88%.

Oncology Institute's earnings in 2026 is -$60,528,000.On average, 5 Wall Street analysts forecast TOI's earnings for 2026 to be -$29,563,593, with the lowest TOI earnings forecast at -$42,422,034, and the highest TOI earnings forecast at -$17,561,069.

In 2027, TOI is forecast to generate -$7,949,212 in earnings, with the lowest earnings forecast at -$7,713,097 and the highest earnings forecast at -$8,264,033.

What is TOI's revenue growth forecast for 2026-2027?

(NASDAQ: TOI) Oncology Institute's forecast annual revenue growth rate of 39.37% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 8.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 26.95%.

Oncology Institute's revenue in 2026 is $461,039,000.On average, 5 Wall Street analysts forecast TOI's revenue for 2026 to be $63,212,962,390, with the lowest TOI revenue forecast at $58,233,882,773, and the highest TOI revenue forecast at $68,198,928,701.

In 2027, TOI is forecast to generate $79,611,164,141 in revenue, with the lowest revenue forecast at $77,247,060,541 and the highest revenue forecast at $82,764,286,088.

What is TOI's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: TOI) forecast ROA is -4.86%, which is lower than the forecast US Medical Care Facilities industry average of 10.03%.

What is TOI's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TOI price target, the average TOI price target is $6.00, with the highest TOI stock price forecast at $7.00 and the lowest TOI stock price forecast at $5.00.

On average, Wall Street analysts predict that Oncology Institute's share price could reach $6.00 by Nov 25, 2026. The average Oncology Institute stock price prediction forecasts a potential upside of 115.83% from the current TOI share price of $2.78.

What is TOI's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: TOI) Oncology Institute's current Earnings Per Share (EPS) is -$53,004.94. On average, analysts forecast that TOI's EPS will be -$0.30 for 2026, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at -$0.18. In 2027, TOI's EPS is forecast to hit -$0.08 (min: -$0.08, max: -$0.08).

What is TOI's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: TOI) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.